FDA opens fast-track for next-gen GLP-1 oral analogs
A regulatory shift could compress timelines from 18 to 9 months for cleared candidates.
Today · Flash DeskNews from the lab. Trends from the clinic. Verdicts from the shelf. Three blocks, zero filler.
What moved the nutraceuticals industry in the last 24 hours.
A regulatory shift could compress timelines from 18 to 9 months for cleared candidates.
Today · Flash DeskThe molecules, protocols and clinics rewriting modern health.
A weight-loss molecule reframed as a longevity tool. Clinics report safer profiles at 1/8 dose.
Read briefing →mTOR inhibition is moving from research labs into elite preventive clinics.
Read briefing →Drip bars in 47 US states. Cost-per-session down 38% YoY.
Read briefing →Plunge tubs + breathwork stack as a metabolic intervention.
Read briefing →Tissue-repair peptides break into the mainstream training market.
Read briefing →CGMs reach mass market; food-as-data narrative dominates.
Read briefing →Independent verdicts on the supplements actually worth your wallet.
Disclosure: Some links on this page are affiliate links. We may earn a commission at no extra cost to you. Editorial picks remain independent.
Bio-available EPA/DHA with astaxanthin co-factor — zero fishy reflux in our 30-day trial.
Check price →Most-tolerated magnesium for cognition. Sleep latency dropped 22% on average.
Check price →Pharmacy-grade NMN at a fair price; third-party verified above 99% purity.
Check price →The boring winner. 5g micronised, sub-cent per gram, no bloating.
Check price →